| 0 (0%) | 12-05 09:28 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 23.51 |
1-year : | 27.46 |
| Resists | First : | 20.12 |
Second : | 23.51 |
| Pivot price | 18.91 |
|||
| Supports | First : | 18.63 |
Second : | 17.7 |
| MAs | MA(5) : | 19.61 |
MA(20) : | 18.84 |
| MA(100) : | 19.02 |
MA(250) : | 0 | |
| MACD | MACD : | 0.2 |
Signal : | 0 |
| %K %D | K(14,3) : | 95.3 |
D(3) : | 90.8 |
| RSI | RSI(14): 65.7 |
|||
| 52-week | High : | 20.42 | Low : | 14.34 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ PFS ] has closed below upper band by 9.2%. Bollinger Bands are 87.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 20.13 - 20.2 | 20.2 - 20.27 |
| Low: | 19.73 - 19.83 | 19.83 - 19.91 |
| Close: | 19.89 - 20.01 | 20.01 - 20.13 |
Fri, 05 Dec 2025
CleanTech poised for CEOL and PFS progress early next year - Vox Markets
Thu, 04 Dec 2025
Freegold tests starter pit ahead of PFS - North of 60 Mining News
Wed, 03 Dec 2025
West Pharma Simplifies PFS with Single-Source System - Packaging Digest
Wed, 03 Dec 2025
PFS Bancorp (OTCQB: PFSB) adds 155,693-share repurchase to ongoing 172,500-share plan - Stock Titan
Wed, 03 Dec 2025
Imvax to explore FDA pathway for glioblastoma candidate despite PFS miss - Clinical Trials Arena
Wed, 03 Dec 2025
Despite PFS miss, Imvax claims “potential watershed moment” in glioblastoma - The Pharma Letter
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 131 (M) |
| Shares Float | 126 (M) |
| Held by Insiders | 2.6 (%) |
| Held by Institutions | 73 (%) |
| Shares Short | 3,670 (K) |
| Shares Short P.Month | 3,280 (K) |
| EPS | 1.99 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 21.18 |
| Profit Margin | 30.6 % |
| Operating Margin | 53.3 % |
| Return on Assets (ttm) | 1 % |
| Return on Equity (ttm) | 9.5 % |
| Qtrly Rev. Growth | 6.6 % |
| Gross Profit (p.s.) | 6.4 |
| Sales Per Share | 6.4 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 53.9 % |
| Operating Cash Flow | 613 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 10.06 |
| PEG Ratio | 0 |
| Price to Book value | 0.94 |
| Price to Sales | 3.12 |
| Price to Cash Flow | 4.27 |
| Dividend | 0.23 |
| Forward Dividend | 0 |
| Dividend Yield | 1.1% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|